From: <b class="gmail_sendername">Dr MIRA SHIVA</b> <span dir="ltr"><<a href="mailto:mirashiva@gmail.com">mirashiva@gmail.com</a>></span><br><div class="gmail_quote"><div dir="ltr"><br><div><div><div><br><div class="gmail_quote">
From: <b class="gmail_sendername">The Economic Times</b> <span dir="ltr"><<a href="mailto:etnotifications@indiatimes.com" target="_blank">etnotifications@indiatimes.com</a>></span><br>
<br><br>




<div>
<img src="" alt=" " height="1" width="1"> 
<table style="WIDTH:605px;min-height:18px" align="center">
<tbody>
<tr>
<td>
<div style="BORDER-RIGHT:#dadada 1px solid;BORDER-TOP:#dadada 1px solid;FLOAT:left;BORDER-LEFT:#dadada 1px solid;WIDTH:602px;BORDER-BOTTOM:#dadada 1px solid">
<span class="HOEnZb"><font color="#888888">
</font></span><table style="PADDING-RIGHT:0px;PADDING-LEFT:10px;FLOAT:left;PADDING-BOTTOM:0px;WIDTH:100%;PADDING-TOP:10px">
<tbody>
<tr>
<td style="PADDING-RIGHT:16px;PADDING-LEFT:16px;PADDING-BOTTOM:5px;PADDING-TOP:26px">
<div style="PADDING-RIGHT:0px;PADDING-LEFT:0px;PADDING-BOTTOM:1px;PADDING-TOP:0px;BORDER-BOTTOM:#dadada 3px solid">
<div style="FONT-WEIGHT:bold;FONT-SIZE:31px;COLOR:#02465b;FONT-FAMILY:'Times New Roman'"><a style="COLOR:#02465b;TEXT-DECORATION:none" href="http://etnotifications.indiatimes.com/cl.aspx?param=9SJ%2bZNXP6na9au7560gFeospmkN8rq7chU%2ft2c3%2bQ%2bXfCgzGXbHobg%3d%3d&o=http%3a%2f%2feconomictimes.indiatimes.com%2f" target="_blank"><span style="FONT-SIZE:46px">T</span>HE <span style="FONT-SIZE:46px">E</span>CONOMIC <span style="FONT-SIZE:46px">T</span>IMES</a></div>

</div></td></tr>
<tr>
<td style="PADDING-RIGHT:16px;PADDING-LEFT:16px;PADDING-BOTTOM:5px;PADDING-TOP:5px"><div style="PADDING-RIGHT:0px;PADDING-LEFT:0px;FONT-WEIGHT:bold;FONT-SIZE:12px;PADDING-BOTTOM:7px;PADDING-TOP:0px;BORDER-BOTTOM:#ccc 1px dotted;FONT-FAMILY:Arial,Helvetica,sans-serif">
Click the following to access the shared link:</div>

<div style="PADDING-RIGHT:0px;PADDING-LEFT:0px;FLOAT:left;PADDING-BOTTOM:7px;PADDING-TOP:8px;BORDER-BOTTOM:#ccc 1px dotted"><span style="FONT-SIZE:14px;FONT-FAMILY:Arial,Helvetica,sans-serif"><a style="FONT-WEIGHT:400;FONT-SIZE:15px;COLOR:#024d99;LINE-HEIGHT:20px;FONT-FAMILY:arial;TEXT-DECORATION:underline" href="http://etnotifications.indiatimes.com/cl.aspx?param=9SJ%2bZNXP6na9au7560gFeospmkN8rq7chU%2ft2c3%2bQ%2bXfCgzGXbHobg%3d%3d&o=http%3a%2f%2feconomictimes.indiatimes.com%2fnews%2fnews-by-industry%2fhealthcare%2fbiotech%2fpharmaceuticals%2fnovartis-loses-legal-battle-over-glivec-huge-boost-for-local-drug-cos%2farticleshow%2f19318848.cms%3fintenttarget%3dno%26mailtofriend%3dyes" target="_blank"><b>Novartis loses legal battle over Glivec, huge boost for local drug cos</b></a></span><br>

<span style="FONT-SIZE:14px;FONT-FAMILY:Arial,Helvetica,sans-serif">Novartis' Glivec is priced at Rs 1.2 lakh whereas local generic versions, which feed most of the poor countries of the world, cost a fourth of that.</span><br>


<div style="FLOAT:right;MARGIN:15px 0px;WIDTH:100%;TEXT-ALIGN:right"><a style="FONT-WEIGHT:400;FONT-SIZE:14px;COLOR:#024d99;LINE-HEIGHT:20px;FONT-FAMILY:arial;TEXT-DECORATION:none" href="http://etnotifications.indiatimes.com/cl.aspx?param=9SJ%2bZNXP6na9au7560gFeospmkN8rq7chU%2ft2c3%2bQ%2bXfCgzGXbHobg%3d%3d&o=http%3a%2f%2feconomictimes.indiatimes.com%2fnews%2fnews-by-industry%2fhealthcare%2fbiotech%2fpharmaceuticals%2fnovartis-loses-legal-battle-over-glivec-huge-boost-for-local-drug-cos%2farticleshow%2f19318848.cms%3fintenttarget%3dno%26mailtofriend%3dyes" target="_blank">click here to read the full article >></a></div>


<div style="PADDING-RIGHT:0px;PADDING-LEFT:0px;FONT-SIZE:10px;FLOAT:left;PADDING-BOTTOM:5px;WIDTH:100%;COLOR:#3d3d3d;PADDING-TOP:5px;FONT-FAMILY:arial">This article can also be accessed if you copy and paste the entire address below into your web browser.<br>

<span><a href="http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/novartis-loses-legal-battle-over-glivec-huge-boost-for-local-drug-cos/articleshow/19318848.cms?intenttarget=no&mailtofriend=yes" target="_blank">http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/novartis-loses-legal-battle-over-glivec-huge-boost-for-local-drug-cos/articleshow/19318848.cms?intenttarget=no&mailtofriend=yes</a></span></div>
<br></div></td></tr><tr><td style="FONT-SIZE:10px;PADDING-BOTTOM:15px;COLOR:#3d3d3d;FONT-FAMILY:arial;TEXT-ALIGN:right"><br></td></tr><tr><td style="PADDING-RIGHT:5px;BORDER-TOP:#ccc 1px dotted;PADDING-LEFT:5px;FONT-SIZE:12px;PADDING-BOTTOM:10px;PADDING-TOP:5px;FONT-FAMILY:Arial,Helvetica,sans-serif">
<br></td></tr></tbody></table></div></td></tr></tbody></table></div></div></div></div></div></div><br></div>